NR1H4 and steatosis: By contrast, in diabetic (db/db), obese (ob/ob), or wild-type mice, the use of bile acids or FXR agonists reduces plasma triglycerides, fatty acids, and cholesterol, as well as reducing hepatic lipid/steatosis (Watanabe et al., 2004a; Zhang et al., 2006).